Dr. Kenkre is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2007 - 2010
Tufts Medical CenterResidency, Internal Medicine, 2004 - 2007
University of Michigan Medical SchoolClass of 2004
Certifications & Licensure
WI State Medical License 2010 - 2025
IL State Medical License 2007 - 2014- American Board of Internal Medicine Hematology
Clinical Trials
- TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma Start of enrollment: 2016 Mar 10
Publications & Presentations
PubMed
- Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphom...Julie E Chang, Danielle McQuinn, Meredith Hyun, KyungMann Kim, Vaishalee P Kenkre
Clinical Lymphoma, Myeloma & Leukemia. 2024-10-09 - Maintenance low-dose fixed duration lenalidomide and rituximab following bendamustine and rituximab induction in previously untreated chronic lymphocytic leukemia and ...Julie E Chang, Tuo Wang, KyungMann Kim, Matthew Folstad, Mariah Endres
Leukemia & Lymphoma. 2024-10-01 - 1 citationsAutologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.Mazyar Shadman, Kwang W Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh
Blood Cancer Journal. 2024-07-08
Abstracts/Posters
- The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)Vaishalee P. Kenkre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center AnalysisVaishalee P. Kenkre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...Vaishalee P. Kenkre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
UW Study Provides Potential Treatment Strategy for Aggressive LymphomaJune 12th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
